Drug reference
erythropoietin-beta
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Miscellaneous (Hematopoietic Drugs)
Mechanism of action
Stimulates hemoglobin production by stimulating the erythropoetin receptor of erythroid progenitor cells in the bone marrow. Hemoglobin increase, following a single initial dose, occurs 7 to 15 days after. Erythropoietin is a growth factor for erythroid development.
Common side effects
- Headache
- Hypertension
- Thromboembolic event
Related conditions
Frequently asked questions
What drug class is erythropoietin-beta?
erythropoietin-beta belongs to: Miscellaneous.
How does erythropoietin-beta work?
Stimulates hemoglobin production by stimulating the erythropoetin receptor of erythroid progenitor cells in the bone marrow. Hemoglobin increase, following a single initial dose, occurs 7 to 15 days after. Erythropoietin is a growth factor for erythroid development.
What are the common side effects of erythropoietin-beta?
Headache, Hypertension, Thromboembolic event
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.